Genetic variation in the glucagon
Background Degeneration of organ-specific nervous systems precede major clinical conditions such as heart failure, dementia, diabetic retinopathy, and diabetic neuropathy. Glucagon-like peptide-1 receptor (GLP1R) agonists may have neuroprotective effects, independent of their glucose -lowering effects, and as such may be tools for early prevention of neurodegeneration. We investigated whether ...
Investigational agents for use in the treatment of T2DM include GPR119 and GPR40 receptor agonists that stimulate the release of GLP-1 from L cells. Summarized here is the role of GLP-1 to control blood glucose homeostasis , with special emphasis on the advantages and limitations of GLP-1-based therapeutics.
Pharmacogenomics of GLP
In the treatment of type 2 diabetes, GLP-1 receptor agonists lower blood glucose concentrations, body weight, and have cardiovascular benefits. The efficacy and side effects of GLP-1 receptor agonists vary between people. Human pharmacogenomic studies of this inter-individual variation can provide both biological insight into drug action and provide biomarkers to inform clinical decision ...
CONCLUSIONS— These data suggest that the arcuate GLP-1 receptors are a key component of the GLP-1 system for improving glucose homeostasis by regulating both insulin secretion and glucose production.
Useful Notes on Glp-1 Receptor Genetic Variation And Glucose Homeostasis
Glucagon-like peptide-1 receptor (GLP1R) agonists, such as semaglutide, are used for treating type 2 diabetes mellitus and promoting weight loss. This study investigates genetic and molecular mechanisms underlying GLP1R activation using a novel in silico approach to identify effects on metabolism, glucose and insulin production, gastrointestinal motility, behavior, and satiety. This approach ...
Effects of Naturally Occurring Genetic Variations in Incretin Receptors ...
Such details provide a deeper understanding and appreciation for Glp 1 Receptor Genetic Variation And Glucose Homeostasis.
Insulin secretion by pancreatic β-cells is stimulated by the incretin hormone GLP-1 , producing the "incretin effect". Two common genetic variants of the GLP-1 receptor ( GLP -1R), R131Q and G168S, alter the incretin effect in humans.
Genetic variability in sodium- glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP -1RA in the everyday clinical practice
Gao et al. perform functional profiling of 60 genetic variants of glucagon-like peptide 1 receptor (GLP1R) in vitro, and link variants with impaired GLP1R cell surface expression or cAMP ...
Summarized here is the role of GLP-1 to control blood glucose homeostasis , with special emphasis on the advantages and limitations of GLP-1-based therapeutics.
